FDA Clears Ring for Pulse Oximetry
The US Food and Drug Administration has granted BodiMetrics 510k clearance for its circul pro ring as a pulse oximeter.
The US Food and Drug Administration has granted BodiMetrics 510k clearance for its circul pro ring as a pulse oximeter.
The patient-worn, continuous vital signs monitor allows clinicians to monitor a variety of physiological measurements, including Masimo SET pulse oximetry, noninvasive blood pressure, temperature, respiration rate, and electrocardiography.
Approved for use in the EU since June 2022, the platform is equipped with smart parameter technology that can be used for patients at all levels of acuity.
VitalFlo has launched home-based virtual care services in partnership with Allergy & Asthma Network (AAN).
Read MoreSmartphones equipped with a deep learning algorithm are capable of detecting blood oxygen saturation levels down to 70%, according to a proof-of-principle study published in npj Digital Medicine.
Read MoreRxCap Inc will integrate the Zephyrx cloud spirometry platform will be integrated into RxCap Inc’s remote monitoring platform, enabling its customers to monitor the lung function of their patients and members with serious pulmonary conditions.
Read MoreMedtronic plc has entered into a strategic partnership with BioIntelliSense for the exclusive US hospital and 30-day post-acute hospital to home distribution rights of the BioButton multi-parameter wearable for continuous, connected monitoring.
Read MoreThe FDA will convene a public meeting of its Medical Devices Advisory Committee later this year to discuss evidence about the accuracy of pulse oximeters, according to the agency.
Read MoreA new JAMA-published study of over 7,000 patients found that pulse oximeters overestimated blood oxygen levels in non-white COVID-19 patients, which delayed — or even prevented — administration of COVID medications and care.
Read MoreVitalFlo has partnered with Vitalograph to provide smart respiratory health monitoring through Vitalograph’s range of remote monitoring spirometry devices.
Read MoreThe use of home remote patient monitoring could potentially be associated with 87% fewer hospitalizations, 77% fewer deaths, reduced per-patient costs of $11,472 over standard care.
Read MoreZoll launched its Arrhythmia Management System, a mobile cardiac telemetry solution that adds biometric data to traditional MCT data to help physicians make more informed treatment plans.
Read MoreA study of the Wellinks virtual COPD management solution found that older adults with COPD were highly engaged and satisfied with the mobile app.
Read MoreThe BioButton Rechargeable device allows for continuous multi-parameter monitoring of a broad range of over 20 vital signs and physiologic biometrics for up to 30 days on a single charge.
Read MoreThe latest Philips Capsule Surveillance solution has received 510(k) market clearance from the US FDA, according to a company announcement at HIMSS 2022.
Read More